NCT00346775View on ClinicalTrials.gov

Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)

PHASE3CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

May 1, 2006

Primary Completion Date

June 29, 2006

Study Completion Date

June 29, 2006

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Beclomethasone dipropionate

Beclomethasone dipropionate

DRUG

Flunisolide

Flunisolide

Trial Locations (7)

93720

GSK Investigational Site, Fresno

94102

GSK Investigational Site, San Francisco

94558

GSK Investigational Site, Napa

94598

GSK Investigational Site, Walnut Creek

95117

GSK Investigational Site, San Jose

95128

GSK Investigational Site, San Jose

95678

GSK Investigational Site, Roseville

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00346775 - Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) | Biotech Hunter | Biotech Hunter